Screening for cardiovascular and renal risk factors with subsequent intervention letter is effective in terms of increasing drug treatment for hypertension and/or hyperlipidaemia, but is "definitely not optimal"

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.452, 2004-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Screening for pre-hypertension and elevated cardiovascular risk factors in a Thai community pharmacy

By Pongwecharak Juraporn  

Pharmacy World and Science, Vol. 32, Iss. 3, 2010-06 ,pp. : 329-333

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Cardiovascular Risk Factors in Women

By  

Current Medicinal Chemistry, Vol. 22, Iss. 31, 2015-10 ,pp. : 3580-3596

Bentham Science Publishers

Access to resources Recommend Favorite

Optimal Drug Treatment of Systolic Hypertension in the Elderly

By Pannarale Giuseppe  

Drugs & Aging, Vol. 25, Iss. 1, 2008-01 ,pp. : 1-8

Adis International

Access to resources Recommend Favorite

Cardiovascular risk factors in progressive renal disease

By Harris KPG  

Clinical Medicine, Vol. 2, Iss. 3, 2002-05 ,pp. : 191-194

Royal College Of Physicians

Access to resources Recommend Favorite

Hypertension and Hypercholesterolaemia as Risk Factors for Alzheimer's Disease: Potential for Pharmacological Intervention

By Kivipelto M.  

CNS Drugs, Vol. 16, Iss. 7, 2002-01 ,pp. : 435-444

Adis International

Access to resources Recommend Favorite